Corgenix Announces Participation in Knobias.com 'Corporate Tour 1000' Campaign

Apr 12, 2001, 01:00 ET from Corgenix Medical Corporation

    DENVER, April 12 /PRNewswire/ -- Corgenix Medical Corporation
 (OTC Bulletin Board:   COGX) today announced its participation in the
 Knobias.com "Corporate Tour 1000" campaign.  This "Corporate Tour" video will
 allow Corgenix to show individual investors, as well as institutional
 investors, the company's facilities, management and company operations via the
 Knobias.com web site in streaming media format.  The video tour is presently
 available for viewing at http://www.knobias.com.
     "Knobias.com is pleased to have Corgenix as a participant in the
 'Corporate Tour 1000' campaign," stated Greg Ballard, Knobias COO.  "I feel
 companies are beginning to realize the value of 'third party,' unbiased
 exposure to the investing community.  Knobias.com, originally launched as
 pennyPI.com and relaunched as www.Knobias.com on February 16, 2001, will
 facilitate the distribution of this content to the commercial markets.  We
 have had tremendous interest from the institutional market for our data."
     Corgenix Medical Corporation is based in metropolitan Denver, with its
 international marketing office near Cambridge, England.  Corgenix is focused
 on the development and promotion of specialized diagnostic test kits for
 vascular diseases and immunological disorders, and its diagnostic products are
 commercialized for use in clinical laboratories worldwide.  The Corgenix
 subsidiary, health-outfitters.com, Inc., focuses on consumer healthcare
 products.
     Knobias.com, a privately owned Mississippi based Internet company, is the
 first and largest online resource for unbiased knowledge covering the "Outside
 Markets."  Knobias.com currently maintains the Web's largest electronic
 database of unbiased, current and historical research on over 6,500 public
 companies trading in the "Outside Markets."  These "Outside Market" companies
 include those with little traditional coverage that trade publicly on the
 OTCBB, the Pink Sheets, and the Nasdaq Small Cap market.
     As a policy of complete independence, Knobias.com has not received any
 compensation from Corgenix nor does it hold a position in this security.
 Knobias.com has absolutely no affiliations, material or otherwise, with
 Corgenix.  For more information regarding Knobias.com please visit the web
 site www.Knobias.com or email them at info@Knobias.com, or call
 (601) 978-3399.
     Complete copies of the Corgenix Medical Corporation Form 10-KSB and 10-QSB
 are available at www.sec.gov, or can be obtained by contacting Chris Wolfe,
 investor relations manager of Corgenix: phone (303) 457-4345 ext. 147, or
 e-mail at cwolfe@corgenix.com.
 
 

SOURCE Corgenix Medical Corporation
    DENVER, April 12 /PRNewswire/ -- Corgenix Medical Corporation
 (OTC Bulletin Board:   COGX) today announced its participation in the
 Knobias.com "Corporate Tour 1000" campaign.  This "Corporate Tour" video will
 allow Corgenix to show individual investors, as well as institutional
 investors, the company's facilities, management and company operations via the
 Knobias.com web site in streaming media format.  The video tour is presently
 available for viewing at http://www.knobias.com.
     "Knobias.com is pleased to have Corgenix as a participant in the
 'Corporate Tour 1000' campaign," stated Greg Ballard, Knobias COO.  "I feel
 companies are beginning to realize the value of 'third party,' unbiased
 exposure to the investing community.  Knobias.com, originally launched as
 pennyPI.com and relaunched as www.Knobias.com on February 16, 2001, will
 facilitate the distribution of this content to the commercial markets.  We
 have had tremendous interest from the institutional market for our data."
     Corgenix Medical Corporation is based in metropolitan Denver, with its
 international marketing office near Cambridge, England.  Corgenix is focused
 on the development and promotion of specialized diagnostic test kits for
 vascular diseases and immunological disorders, and its diagnostic products are
 commercialized for use in clinical laboratories worldwide.  The Corgenix
 subsidiary, health-outfitters.com, Inc., focuses on consumer healthcare
 products.
     Knobias.com, a privately owned Mississippi based Internet company, is the
 first and largest online resource for unbiased knowledge covering the "Outside
 Markets."  Knobias.com currently maintains the Web's largest electronic
 database of unbiased, current and historical research on over 6,500 public
 companies trading in the "Outside Markets."  These "Outside Market" companies
 include those with little traditional coverage that trade publicly on the
 OTCBB, the Pink Sheets, and the Nasdaq Small Cap market.
     As a policy of complete independence, Knobias.com has not received any
 compensation from Corgenix nor does it hold a position in this security.
 Knobias.com has absolutely no affiliations, material or otherwise, with
 Corgenix.  For more information regarding Knobias.com please visit the web
 site www.Knobias.com or email them at info@Knobias.com, or call
 (601) 978-3399.
     Complete copies of the Corgenix Medical Corporation Form 10-KSB and 10-QSB
 are available at www.sec.gov, or can be obtained by contacting Chris Wolfe,
 investor relations manager of Corgenix: phone (303) 457-4345 ext. 147, or
 e-mail at cwolfe@corgenix.com.
 
 SOURCE  Corgenix Medical Corporation